Muntendam Pieter 4
4 · BG Medicine, Inc. · Filed Jul 1, 2011
Insider Transaction Report
Form 4
Muntendam Pieter
DirectorPresident, CEO
Transactions
- Award
Stock Option (right to buy)
2011-06-30+162,995→ 162,995 totalExercise: $7.96Exp: 2021-06-30→ Common Stock (162,995 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the shares on June 30, 2012 and vests as to an additional 6.25% of the shares per quarter thereafter until June 30, 2015.